Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (351-360 of 495) with videos related to

Pageof 50
Sort By:
Oncotarget|August 28, 2019
Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomyCornelia Schroeder, Elham Navid-Hill, Jan Meiners, et al.
Oncotarget|January 10, 2018
Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancerMartina Kluth, Simon Jung, Omar Habib, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial CellsMaximilian Lennartz, Dennis Atug, Sebastian Dwertmann Rico, et al.
International Urology and Nephrology|April 2, 2021
Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancerKatharina Möller, Christoph Fraune, Niclas C Blessin, et al.
Virchows Archiv : an International Journal of Pathology|October 8, 2024
TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entitiesKatharina Möller, Tayyaba Gulzar, Maximilian Lennartz, et al.
Oncology Letters|December 15, 2018
High expression of class III β-tubulin in upper gastrointestinal cancer typesDoris Höflmayer, Eray Öztürk, Cornelia Schroeder, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Large-Scale Tissue Microarray Evaluation Corroborates High Specificity of High-Level Arginase-1 Immunostaining for Hepatocellular CarcinomaMaximilian Lennartz, Eva Gehrig, Sören Weidemann, et al.
Cancers|March 10, 2022
PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic PowerAlexandra M Poos, Cornelia Schroeder, Neeraja Jaishankar, et al.
International Urology and Nephrology|December 16, 2024
PLAP expression is linked to invasive tumor growth in urothelial carcinoma of the bladderHenning Plage, Kira Furlano, Sebastian Hofbauer, et al.
Disease Markers|January 25, 2020
Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal TissuesSimon Kind, Christina Merenkow, Franziska Büscheck, et al.
Pageof 50

Showing results (351-360 of 495) with videos related to

Sort By:
Pageof 50
Oncotarget|August 28, 2019
Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomyCornelia Schroeder, Elham Navid-Hill, Jan Meiners, et al.
Oncotarget|January 10, 2018
Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancerMartina Kluth, Simon Jung, Omar Habib, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial CellsMaximilian Lennartz, Dennis Atug, Sebastian Dwertmann Rico, et al.
International Urology and Nephrology|April 2, 2021
Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancerKatharina Möller, Christoph Fraune, Niclas C Blessin, et al.
Virchows Archiv : an International Journal of Pathology|October 8, 2024
TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entitiesKatharina Möller, Tayyaba Gulzar, Maximilian Lennartz, et al.
Oncology Letters|December 15, 2018
High expression of class III β-tubulin in upper gastrointestinal cancer typesDoris Höflmayer, Eray Öztürk, Cornelia Schroeder, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Large-Scale Tissue Microarray Evaluation Corroborates High Specificity of High-Level Arginase-1 Immunostaining for Hepatocellular CarcinomaMaximilian Lennartz, Eva Gehrig, Sören Weidemann, et al.
Cancers|March 10, 2022
PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic PowerAlexandra M Poos, Cornelia Schroeder, Neeraja Jaishankar, et al.
International Urology and Nephrology|December 16, 2024
PLAP expression is linked to invasive tumor growth in urothelial carcinoma of the bladderHenning Plage, Kira Furlano, Sebastian Hofbauer, et al.
Disease Markers|January 25, 2020
Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal TissuesSimon Kind, Christina Merenkow, Franziska Büscheck, et al.
Pageof 50